![](/img/cover-not-exists.png)
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy
J.M. Millis, D.C. Cronin, K.A. Newell, J.B. Piper, E.S. Woodle, D.S. Bruce, H. Conjeevaram, A.L. Baker, J.R. ThistlethwaiteVolume:
29
Year:
1997
Language:
english
DOI:
10.1016/s0041-1345(96)00671-9
File:
PDF, 106 KB
english, 1997